Новое в морфогенезе и эпидемиологии рака яичников
https://doi.org/10.17650/1994-4098-2012-0-2-39-43
Аннотация
В обзоре литературы, посвященном патогенезу и эпидемиологии рака яичников (РЯ), подробно рассматриваются факторы риска развития данного заболевания, такие как особенности пищевых привычек, роль массы тела, контрацепции, родов и возраста начала половой жизни. Обсуждаются модели пищевого и полового поведения, количество менструаций и овуляций за весь репродуктивный период. Анализируются работы авторов, изучавших влияние курения и употребления алкоголя на риск развития РЯ. Обсуждаются новые данные об изменениях в маточной трубе как о возможном источнике РЯ.
Список литературы
1. Ries L., Miller B.A., Hankey B.F. SEER cancer statistics review 1973–1991. National Institutes of Health, 1994.
2. Howe H.J., Wingo P.A., Thun M.J. et al. Annual report to the nation on the status of cancer. Int J Gynecol Cancer 2001; 93: 824–42.
3. NIH Consensus Development Conference Statement. Ovarian cancer: screening, treatment and follow-up. Gynecol Oncol 1994;55:4–14.
4. Манухин И.Б., Высоцкий М.М. Современные методы профилактики рака яичников. Вопр гинек акуш
5. перинатол 2003;2(3):37–44.
6. Урманчеева А.Ф., Мешкова И.Е. Вопросы эпидемиологии и диагностики рака яичников. Практ онкол 2000;(4): 7–13.
7. World Cancer Research Fund. Ovary, food, nutrition, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 1997. P. 288–93.
8. Liede A., Karlan B., Baldwin R. Cancer incidence in a population of Jewish women at risk of ovarian cancer. J Clin Oncol 2002;20:1570–7.
9. Menczer J., Liphshittz I., Barchana M. A decreasing incidence of ovarian carcinoma in Israel. Int J Gynecol Cancer 2006;(16):41–4.
10. Runnenbaum I.B., Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001;123:73–9.
11. Whittemore A.S., Harris R., Itnyre J. et al. Characteristics relating to ovarian cancer risk: collaborative
12. analysis of 12 US case control studies. Am J Epidemiol 1992;136:1212–20.
13. Cooper G.S., Schildkraut J.M., Whittemore A.S. et al. Pregnancy recency and risk of ovarian cancer. Cancer Causes Control 1999;10:397–402.
14. Venn A., Watson L., Bruinsma F. et al. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet 1999; 354:1586–90.
15. Zreik T.G., Ayoub C.M., Hannoun A. Fertility drugs and risk of ovarian cancer: dispelling the myth. Curr Opin Obstet Gynecol 2008;20(3):313–9.
16. Risch H.A., Marret L.D., Howe G.R. Parity, contraception, infertility and the risk of epithelial ovarian cancer. Am J Epidemiol 1994;140:585–91.
17. Vessey M., Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004. Br J Cancer 2006; [Epub ahead of print].
18. Hankinson S.E., Hunter D.J., Colditz G.A. et al. Tubal ligation, hysterectomy and risk of ovarian
19. cancer: a prospective study. JAMA 1993;270(23):2813–8.
20. Riman Т., Persson I., Nilson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol Oxf 1998;49(6):695–707.
21. WHO classification of tumours. Lyon: IARCPRESS, 2003.
22. Mahdavi A., Pejovic T., Nezhat F. Induction of ovulation and ovarian cancer: a critical review of the literature. Fertil Steril 2006;85(4):819–26.
23. Garg P.P., Kerlikowske K., Subal L. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta- analysis. Obstet Gynecol 1998;92:472–9.
24. Purdie D.M., Bain C.J., Siskind V. Hormone replacement therapy and the risk of epithelial ovarian cancer. Br J Cancer 1999;81:559–64.
25. Shu X.O., Gao Y.T., Yuan J.M. et al. Dietary factors and epithelial ovarian cancer. Br J Cancer 1989;59:92–6.
26. Edefonti V., Decarli A., La Vecchia C. Nutrient dietary patterns and the risk of breast and ovarian cancers. Int J Cancer 2008;122(3):609–13.
27. Mommers M., Schouten L.J., Goldbohm R.A. et al. Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 2005; [Epub ahead of print].
28. Mommers M., Schouten L.J., Goldbohm R.A. et al. Consumption of vegetables and fruits and risk of ovarian carcinoma. Cancer 2005;104(7):1512–9.
29. Peterson N.B., Trentham-Dietz A., Newcomb P.A. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer 2006; [Epub ahead of print].
30. Wood C.E., Register T.C., Franke A.A. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res 2006;66(2):1241–9.
31. Итон С.Б., Хэтчер Р.А., Коннер М.Дж. и др. Рак женских репродуктивных органов и процесс эволюции. Вопр онкол 1991;37(9–10):899–907.
32. Koushik A., Hunter D.J., Spiegelman D. Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies. Int J Cancer 2006; [Epub ahead of print].
33. Rossi M., Negri E., Lagiou P. Flavonoids and ovarian cancer risk: A case-control study in Italy. Int J Cancer 2008; [Epub ahead of print].
34. Манухин И.Б., Высоцкий М.М., Кушлинский Н.Е. Молекулярно-биологические факторы в патогенезе и хирургическом лечении опухолей яичников. М.: Династия, 2007.
35. Greer J.B., Howe H.J., Wingo P.A. et al. Anthropometry and the risk of epithelial ovarian cancer. Cancer 2006; [Epub ahead of print].
36. Engeland A., Tretli S., Bjorge T. Height, body mass index, and ovarian cancer: a follow-up of 1, 1 million Norwegian women. J. Nat Cancer Int 2003;95(16):1244–8.
37. Weiderpass E., Margolis K.L., Sandin S. Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 2006; [Epub ahead of print].
38. Bertone E.R., Wilett W., Rosner B.A. et al. A prospective study of recreational physical activity and ovarian cancer. J Nat Cancer Int 2001;93(12):942–8.
39. Hall D., McCarthy К. The significance of the postmenopausal simple adnexal cyst. J Ultrasound Med 1989;503–5.
40. Genkinger J.M., Hunter D.J., Spiegelman D. Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 2006;21; [Epub ahead of print].
41. Jordan S.J., Whiteman D.C., Purdie D.M. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006; [Epub ahead of print].
42. Baker J.A., Odunuga O.O., Rodabaugh K.J. et al. Active and passive smoking and risk of ovarian cancer. Int J Gynecol Cancer 2006;(16 Suppl):211–8.
43. Винокуров В.Л. Рак яичников. СПб.: Фолиант, 2004.
44. Kurman R.J., Shih I.M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34(3):433–43.
45. Kurman R.J., Shih I.M. Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008; [Epub ahead of print].
46. Shih I.M., Kurman R.J. Ovarian tumor genesis: a proposed model based
47. on morphological and molecular genetic analysis. Am J Pathol 2004;164(5):1511–8.
48. Vang R., Shih I.M., Kurman R.J. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 2009; 16(5):267–82.
49. Levanon K., Ng V., Piao H.Y. et al. Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 2010; 25–29(8):1103–13.
50. Salvador S., Gilks B., Köbel M. et al. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer 2009;19(1):58–64.
51. Vicus D., Shaw P.A., Finch A. et al. Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers. Gynecol Oncol 2010;118(3):295–8.
52. Хансон Е.П., Имянитов Е.Н. Молекулярная генетика рака яичников. Практ онкол 2000;(4):3–6.
53. Hughes C.L., Wall L.L., Creasman W.T. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause. Gynecol Oncol 1991;40(1):42–5.
54. Карселадзе А.И. Некоторые проблемы клинической морфологии эпителиальных опухолей яичников. Практ онкол 2000;(4):14–8.
55. Глазунов М.Ф. Опухоли яичников. Л.: Медгиз, 1961.
56. Колосов А.Е. Опухоли яичников и прогноз для больных. Киров: Вятка, 1996.
57. Ашрафян Л.А., Киселёв В.И. Опухоли репродуктивных органов (этиология и патогенез). М.: ДГТ, 2008.
58. Синельникова Т.И. Клинико-иммунологическая и гистохимическая характеристика эпителиальных опухолей яичников. Автореф. дис. ... канд. мед. наук. М., 2004.
Рецензия
Для цитирования:
Высоцкий М.М. Новое в морфогенезе и эпидемиологии рака яичников. Опухоли женской репродуктивной системы. 2012;(2):39-43. https://doi.org/10.17650/1994-4098-2012-0-2-39-43
For citation:
Vysotsky M.M. The innovation in the morphogenesis and epidemiology of ovarian cancer. Tumors of female reproductive system. 2012;(2):39-43. (In Russ.) https://doi.org/10.17650/1994-4098-2012-0-2-39-43
Просмотров:
503
Послать статью по эл. почте 